Hospital-acquired infections (HAIs) are a global public health concern. As the COVID-19
pandemic continues, its contribution to mortality and antimicrobial resistance (AMR) grows …

The SARS-CoV-2 pandemic caused an increase in intensive care unit (ICU) hospitalizations
with a rise in morbidity and mortality; nevertheless, there is still little evidence on the impact …

Introduction: The pressure of the COVID-19 pandemic on healthcare systems led to limited
roles of infectious diseases services, increased rates of irrational use of antimicrobials, and …

Effects of COVID-19 pandemic on healthcare-associated infections, antibiotic resistance and
consumption rates in intensive care units - PMC Back to Top Skip to main content NIH NLM …

Background The prevalence of resistant hospital infections in the intensive care unit (ICU)
increases mortality and antibiotic resistance. COVID-19 pandemic may have unintended …

The COVID-19 pandemic may have had an effect on antimicrobial resistance. We compared
the prevalence of ESKAPE multidrug-resistant (MDR) bacterial infections in COVID-19 …

Antimicrobial resistance (AMR) is a global health issue that plays a significant role in
morbidity and mortality, especially in immunocompromised patients. It also becomes a …

Studies suggest that the incidence of coinfections in patients with the coronavirus disease
2019 (COVID-19) is low, but a large number of patients receive antimicrobials during …

Antimicrobial resistance (AMR) is a global concern, and antibiotic use has risen throughout
the COVID-19 pandemic. Up to 75% of COVID-19 patients are treated with antibiotics …

Background Few small studies have described hospital-acquired infections (HAIs) occurring
in patients with COVID-19. Research Question What characteristics in critically ill patients …